iPS Cells & Regenerative Medicine– category –
-
Parkinson’s Regenerative Medicine Milestone: iPSC-Derived Dopamine Precursors Safely Transplanted in First-in-Human Trial
Parkinson's NSW Sweden Overview A pivotal clinical trial led by Lund University has confirmed the safety and feasibility of transplanting iPSC-derived dopamine precursor cells into Parkinson's disease patients. Published in Nature Medici... -
Rewriting Sickle Cell Disease: The Promise of In Vivo Gene Editing and the Global Equity Challenge
Current Opinion in Hematology USA Overview The quest to cure sickle cell disease (SCD) hinges on establishing durable, healthy hematopoiesis without significant toxicity. While cutting-edge in vivo and prenatal hematopoietic stem cell (H... -
Breakthrough: Schwann Cell Exosomes Dramatically Improve Recovery from Severe Peripheral Nerve Injuries
The Miami Project USA Overview Researchers at the University of Miami Miller School of Medicine have demonstrated in preclinical models that exosomes derived from Schwann cells significantly accelerate functional recovery following sever... -
CRISPR Gene Editing: Engineering Durable Cures for Congenital Diseases through Stem Cell and Liver Targeting
Liv Hospital Turkey Overview CRISPR gene editing technology promises a revolutionary approach to fundamentally cure congenital diseases by precisely correcting underlying genetic errors. By targeting the liver and hematopoietic stem cell... -
Autologous iPSCs from PAD Patients Demonstrate Therapeutic Equivalence to Healthy Donors, Propelling Personalized Vascular Regeneration
CELL STEM CELL International Overview A recent study has demonstrated that induced pluripotent stem cells (iPSCs) and their endothelial cell derivatives (iPSC-ECs) generated from peripheral artery disease (PAD) patients exhibit character... -
Next-Gen Brain Organoids Reveal How APOE4 Astrocytes Drive Alpha-Synuclein Pathology, Unlocking New Therapeutic Targets
ALZFORUM USA Overview A novel mechanism by which APOE4, a major Alzheimer's risk gene, exacerbates neuropathology has been published in Cell Stem Cell, leveraging a newly developed human brain organoid model termed 'miBrains.' This six-c... -
Watchmaker Genomics Bolsters Global Supply Chain, Doubles Manufacturing Capacity with 100,000 Sq Ft Boulder Facility
Longmont Times-Call USA Overview Life sciences firm Watchmaker Genomics Inc. has significantly expanded its global manufacturing capabilities by securing approximately 100,000 square feet of new production space in Boulder, Colorado. Thi... -
Scaling Viral Vector Manufacturing: The Bottleneck to Gene Therapy’s Broader Impact
Cytiva International Overview As gene therapies expand their application beyond rare diseases, the industry faces an urgent need for efficient, consistent, and large-scale viral vector manufacturing. This demand necessitates comprehensiv... -
Twenty Years of iPSCs: From Bespoke Models to Standardized Engineered Biologics
Nature Medicine International Overview Marking two decades since their discovery, a seminal review by Joseph Wu and colleagues in *Cell Stem Cell* chronicles the remarkable evolution of induced pluripotent stem cell (iPSC) technology. Th... -
Comprehensive Analysis Reveals iPSC Potential in CAR-T Therapy for Cancer, Highlights Key Challenges
Research Journal of Pharmacy and Technology India Overview A comprehensive review analyzes the therapeutic potential and inherent risks of hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells...
